EQRX - EQRx lower as CFO departs

2023-03-13 09:29:42 ET

• EQRx ( NASDAQ: EQRX ), a biotech focused on oncology and immune-inflammatory diseases fell ~3% pre-market Monday after announcing the resignation of Jami Rubin, its Chief Financial Officer as well as principal financial officer and principal accounting officer.
• The company said that the resignation which takes effect on Mar. 31 “is not related to a disagreement with EQRx on any matter relating to EQRx’s operations, policies or practices.” EQRx ( EQRX ) plans to conduct an executive search to find its next CFO.
• After Ms. Rubin tendered her resignation, the board of EQRx ( EQRX ) has appointed Melanie Nallicheri, the company’s President and Chief Executive Officer as the new principal financial officer, with immediate effect.
• Ms. Nallicheri took over as CEO and President of the company in Sep. 2021 after serving as the President and Chief Operating Officer of its subsidiary EQRx International since Aug. 2019.

For further details see: